Procter & Gamble Hygiene and Health Care Ltd Q1 FY27 Results — Earnings Call Analysis
Published 24 Jun 2026 | Personal Products | Market Cap: ₹31.5K Cr
- The company expects balanced and sustained long-term growth, focusing on consumer-centric innovation and category development. - The company aims for sustained double-digit earnings growth over the medium term.
From Procter & Gamble Hygiene and Health Care Ltd's Q4 FY26 earnings-call transcript · updated 24 Jun 2026.
Price
₹9,003
Market Cap
₹31.5K Cr
P/E Ratio
36.7
Revenue Rank
Margin Rank
How does Procter & Gamble Hygiene and Health Care Ltd rank in Personal Products?
Compare Procter & Gamble Hygiene and Health Care Ltd against every Personal Products company this quarter on revenue, margins and earnings-call signals.
Procter & Gamble Hygiene and Health Care Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹941 Cr, net profit ₹153 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 4- →The company expects balanced and sustained long-term growth, focusing on consumer-centric innovation and category development.
- →Feminine hygiene category is projected to grow at a healthy mid to high single-digit rate.
- →Healthcare sub-categories are growing at about 2-3%, with some recent volatility due to seasonal factors like monsoons.
- →Focus on evolving sub-segments within categories, e.g., night-time feminine hygiene products and period panties, to drive growth.
- →Strategy emphasizes continuous investment in superior products, effective marketing, and enhanced go-to-market capabilities to win consumer preference.
- →Despite recent flat sales, profit growth and margin expansion reflect productivity savings fueling reinvestment.
- →Growth drivers include volume recovery, premiumization, market share gains, pricing, and operating leverage.
- →The company is committed to navigating macro-economic headwinds while capturing opportunities presented by evolving consumer needs and competitive landscape.
📈 Profitability & Margins
Rank 3- →The company aims for sustained double-digit earnings growth over the medium term.
- →Growth drivers include volume recovery, premiumization, market share gains, pricing, and operating leverage.
- →Focus remains on winning with consumers via innovation, superior products, and consumer-centric strategies.
- →The Integrated Growth strategy centers on balanced growth through investment in consumer understanding, engagement, and innovation.
- →Margin improvement is prioritized via cost savings and productivity embedded in the operating model.
- →Multi-year savings and productivity programs are key to fueling growth investments and margin expansion.
- →Despite a flat topline recently, strong bottom-line growth and a 1-point structural margin improvement were achieved.
- →The company foresees challenges from macro-economic volatility but remains confident in navigating these through its robust strategy.
🏗️ Capital Expenditure Plans
No information- →When asked about key areas of investment by the Parent company and future investment outlook, the company refrained from providing any details.
- →Similarly, questions on manufacturing footprint expansion and buyback of shares were not answered.
- →The company explicitly stated they will withhold sharing unpublished price sensitive or confidential information to protect competitive advantage.
- →Overall, no specific current or future capital expenditure or strategic investment plans were disclosed in the document.
💰 Fundraising & Capital Structure
No information- →The management did not explicitly address any current or future fundraising plans through debt or equity in the provided transcript.
- →During the Q&A on page 17, the company declined to answer questions regarding buyback of shares or similar unpublished price-sensitive information to protect competitive advantage.
- →No information on fundraising activities, whether debt or equity, was shared in the transcript.
- →The company emphasized focus on internal cost savings, productivity programs, and balanced growth strategy to fund investments.
- →They highlighted strong cash flow through operational performance without mention of external capital raising.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Procter & Gamble Hygiene and Health Care Ltd Q1 FY27 results?
- The company expects balanced and sustained long-term growth, focusing on consumer-centric innovation and category development. - The company aims for sustained double-digit earnings growth over the medium term.
What is Procter & Gamble Hygiene and Health Care Ltd share price analysis?
Procter & Gamble Hygiene and Health Care Ltd currently shows a neutral. The stock trades at a P/E of 36.7 with a market cap of ₹31,506. Investors should review the full earnings analysis for detailed insights.
Is Procter & Gamble Hygiene and Health Care Ltd planning capital expenditure?
- When asked about key areas of investment by the Parent company and future investment outlook, the company refrained from providing any details.
Keep Procter & Gamble Hygiene and Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.